1. A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies
   A Spreafico et al, 2015, British Journal of Cancer CrossRef
2. Collaboration of geldanamycin-activated P70S6K and Hsp70 against beta-amyloid-induced hippocampal apoptosis: an approach to long-term memory and learning
   Nayereh Zare et al, 2015, Cell Stress and Chaperones CrossRef
3. Novel therapeutics for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors
   Satya Das et al, 2021, Therapeutic Advances in Medical Oncology CrossRef
4. HSP90 inhibitor NVP-AUY922 enhances TRAIL-induced apoptosis by suppressing the JAK2-STAT3-Mcl-1 signal transduction pathway in colorectal cancer cells
   Dae-Hee Lee et al, 2015, Cellular Signalling CrossRef
5. Chaperone-mediated autophagy degradation of IGF-1Rβ induced by NVP-AUY922 in pancreatic cancer
   Nina Xue et al, 2019, Cellular and Molecular Life Sciences CrossRef
6. Inhibition of Heat Shock Protein 90 as a Novel Platform for the Treatment of Cancer
   Chang Gao et al, 2019, Current Pharmaceutical Design CrossRef
7. Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors
   Sylvia L. Asa et al, 2021, Endocrine Pathology CrossRef
8. A Homogeneous Polysaccharide from Fructus Schisandra chinensis (Turz.) Baill Induces Mitochondrial Apoptosis through the Hsp90/AKT Signalling Pathway in HepG2 Cells
   Yonglin Chen et al, 2016, International Journal of Molecular Sciences CrossRef
9. Hsp90 inhibition by AUY922 as an effective treatment strategy against myxoid liposarcoma
   Sara Steinmann et al, 2015, Cancer Letters CrossRef
10. Neuroendocrine Neoplasms of the Small Intestine
    Shabnam Seydafkan et al, 2016, Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic Advances CrossRef
11. 18F-Radiolabeling and Preliminary Evaluation of a HSP90 ligand
    P. Nordeman et al, 2021, European Journal of Pharmaceutical Sciences CrossRef
12. The radiosensitizer Onalespib increases complete remission in 177Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts
    Sara Lundsten et al, 2020, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
13. The potent activation of Ca2+-activated K+ current by NVP-AUY922 in the human pancreatic duct cell line (PANC-1) possibly independent of heat shock protein 90 inhibition
    Nai-Jung Chiang et al, 2015, Journal of Pharmacological Sciences CrossRef
14. The active Hsc70/tau complex can be exploited to enhance tau turnover without damaging microtubule dynamics
    Sarah N. Fontaine et al, 2015, Human Molecular Genetics CrossRef
15. Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets
    Chandra Maharjan et al, 2021, Cancers CrossRef
16. A novel insight into the anticancer mechanism of metformin in pancreatic neuroendocrine tumor cells
    E. Vitali et al, 2020, Molecular and Cellular Endocrinology CrossRef
17. TRAP1: a viable therapeutic target for future cancer treatments?
    Giacomo Lettini et al, 2017, Expert Opinion on Therapeutic Targets CrossRef
18. Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors
    Ana J. Rodrigues Moita et al, 2020, International Journal of Molecular Sciences CrossRef
19. Re-examining HSPC1 inhibitors
    Sheah Lin Lee et al, 2017, Cell Stress and Chaperones CrossRef
20. A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition
    Kevin Shee et al, 2020, Clinical Cancer Research CrossRef
21. The HSP90 inhibitor onalespib potentiates 177Lu‑DOTATATE therapy in neuroendocrine tumor cells
    Sara Lundsten et al, 2019, International Journal of Oncology CrossRef
22. Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets
    E T Aristizabal Prada et al, 2018, Endocrine Connections CrossRef
23. New insights into molecular chaperone TRAP1 as a feasible target for future cancer treatments
    Xiao-Tong Li et al, 2020, Life Sciences CrossRef